Prelude Therapeutics Incorporated

NASDAQ:PRLD

0.7069 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -127.173-121.832-115.438-111.694-56.929-27.57-14.68
Depreciation & Amortization -2.8671.1691.3240.9150.5420.3820.149
Deferred Income Tax 0001.364000
Stock Based Compensation 21.34525.61625.14420.9315.5830.8460.18
Change In Working Capital 4.216-10.4790.9323.6254.6160.6671.382
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 3.305-2.27-0.3473.9031.1570.5460.721
Other Working Capital 0.911-8.2091.279-0.2783.4590.1210.661
Other Non Cash Items 1.591-1.5374.3091.3280.0110.010.015
Operating Cash Flow -102.888-107.063-83.729-83.531-46.177-25.665-12.954
Investing Activities:
Investments In Property Plant And Equipment -0.764-3.513-3.019-2.323-0.621-0.78-0.529
Acquisitions Net 00-0.0850000
Purchases Of Investments -52.694-221.633-119.223-261.48000
Sales Maturities Of Investments 143.649190.5203.9330000
Other Investing Activites 000.085-0.261000
Investing Cash Flow 90.191-34.64681.691-263.803-0.621-0.78-0.529
Financing Activities:
Debt Repayment -0.395000-0.258-0.1240
Common Stock Issued 0.379135.7310.389161.424166.6329.85317.937
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 0.2751.3450.8153.47379.85629.85317.937
Financing Cash Flow -0.12136.3950.815164.897246.22829.72917.937
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -12.817-5.314-1.223-182.437199.433.2844.454
Cash At End Of Period 16.51829.33534.64935.872218.30918.87915.595